Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Behind the image of a horse brain cell infected with Eastern Equine Encephalitis (EEE) lies a sobering truth: this mosquito-borne virus is far more lethal than commonly understood, and pathologists, virologists, and researchers at LSU Diagnostics are working to better understand and fight it. EEE is found in the eastern, Gulf Coast and north-central regions of the United States, as well as parts of Central and South America and the Caribbean. Horses in areas with dense mosquito populations—such as swamps, coastal marshes, and coves—are at greater risk of contracting the virus. The sedentary “black tail mosquito” (Culiseta melanura) primarily transmits the virus to birds. However, other very active common mosquito species, referred to as "bridge vectors," can transmit the virus from birds to mammals such as humans and horses. "As the summer goes on, we typically have more positive cases as the temperature goes up," says Alma Roy, Ph.D. (LSU 2000), interim director of LSU Diagnostics. Louisiana is no stranger to West Nile virus, but Roy says LSU Diagnostics is seeing an unusual uptick in EEE this year. Though most common in horses, the disease can also strike humans, leading to deadly brain inflammation. In horses, it may cause inflammation of both the brain and the heart. "Necropsy and serological testing at LSU Diagnostics have confirmed at least fourteen positive cases in horses thus far. It's early in the year to see this many. We're seeing some West Nile, but more EEE than West Nile," Roy said. Horses are especially vulnerable to EEE, with mortality rates ranging from 75% to 90%. Survivors frequently suffer lasting neurological damage. Humans fare somewhat better, but the disease remains serious—about 30% of people who develop severe EEE die from the infection. "Many survive a West Nile virus infection, but EEE can be unforgiving. Be careful," warns Dr. Fabio Del Piero, pathologist at LSU Diagnostics and professor at LSU Vet Med. Since treatment is limited and mostly supportive, prevention is critical. Every day, LSU Diagnostics works to make that prevention possible. Roy reminds the public that vaccination and mosquito bite prevention are key: "Horses can be vaccinated. We encourage animals to be vaccinated for EEE and West Nile virus. And for humans, of course, it's the prevention of mosquito bites.” EEE is one of several life-threatening diseases diagnosed by LSU Diagnostics. Our team provides rapid, accurate disease detection through tissue and fluid testing as well as post-mortem diagnostics. LSU Diagnostics also supports statewide mosquito-virus surveillance to protect both animals and people. Together, LSU Diagnostics and LSU Vet Med play a critical role in diagnosing and responding to threats like EEE and West Nile virus — for the health of horses, livestock, wildlife, and the people who care for them. Original article posted here.
LSU Expert Christine Navarre on the Threat of New World Screwworms
The New World screwworm (NWS), also known as the primary screwworm, is the larvae of the fly Cochliomyia hominivorax. Unlike the larvae (maggots) of other flies that only feed on dead tissue, the NWS feeds on live tissue. This leads to more severe and potentially deadly consequences which threatens livestock and wildlife populations. Prior to their eradication form the United States, NWS were a major economic burden to the production of livestock, especially in the in the southwestern U.S. and Florida. The U.S. Department of Agriculture estimates that the U.S. livestock industry saves approximately $900 million a year as a result of NWS eradication. Other benefits of eradication and control are enhanced human and animal health and welfare and increased survival of endangered wild animal species. The NWS fly was eradicated from the U.S. in 1966 with the release of sterile male flies to control the population. This status is maintained through the Panama-U.S. Commission for the Eradication and Prevention of the Cattle Borer Worm (COPEG) which releases millions of sterile flies weekly along the Panama-Colombia border to create a barrier preventing the northward spread of screwworms. Due to these efforts, it is now found primarily in tropical areas of South America and some Caribbean Islands, including Cuba. In 2016 NWS were found in Key Deer in the Florida Keys. The source of the outbreak was never determined. Rapid recognition of the problem and response with the release of sterile flies quickly eradicated the problem but this incident illustrates the importance of remaining vigilant. In November, NWS was detected in Mexico near the Guatemala border. The USDA Animal and Plant Health Inspection Service (APHIS) has imposed immediate import restrictions on animal commodities from Mexico. They are also intensifying efforts to prevent the northward spread of NWS by collaborating with Mexican and Central American authorities and urging livestock producers along the southern U.S. border to monitor their livestock and pets for signs of NWS. Any suspected cases should be reported immediately. Clinical Signs NWS can infest any warm-blooded animal including livestock, pets, wildlife, birds and occasionally humans. Common sites of infestation are any fresh or old wounds, warts, tumors, tick bites and antlers in shedding. Wounds left from management procedures, such as dehorning, branding, ear tagging, tail docking and shearing, can become infested. The eyes, nose, vulva and prepuce are also vulnerable, as well as the umbilicus in newborn mammals. Animals infested with NWS may show the following signs: Presence of maggots in wounds or body openings Wounds with a foul odor, bloody drainage or white/cream-colored drainage (eggs) Depression, reduced appetite, weight loss Isolation and/or signs of discomfort, head shaking Fever and other signs of secondary infection Diagnosis and Reporting Maggots found on animals showing the above clinical signs should be sent to a veterinarian or veterinary diagnostic lab for identification to distinguish NWS larvae from other more common fly larvae. In Louisiana larvae can be sent to the Louisiana Animal Disease Diagnostic Laboratory (www.lsu.edu/vetmed/laddl). Larvae should be placed in 70% alcohol for submission to the diagnostic laboratory. It is very important to immediately report any NWS infestations to the Louisiana Department of Agriculture and Forestry. A reported case will not result in herd depopulation but will allow animal health officials to take steps to help you manage your animals and prevent spread. Early detection and rapid response are critical to controlling this parasite. Treatment Immediate veterinary care should be sought to remove larvae and properly treat with insecticides. Wound care is also important to speed healing and prevent reinfestation. Prevention Treatment of NWS can be difficult, and eradication is very costly, so prevention of infestations is essential. Adult NWS flies can travel up to 12 miles to lay eggs, and eggs can be transported by animals and people traveling from infested areas. This necessitates constant vigilance to ensure that reintroduction into the U.S. does not occur. Preventative steps include: Regularly inspect livestock and pets for cuts, wounds, scabs and tick infestations. Closely monitor the umbilicus of newborn livestock, vulva of females and prepuce of males. Use insect repellant and wound dressings to prevent fly strike. Report any unusual wildlife or bird deaths to the Louisiana Wildlife and Fisheries. Pay close attention to nasal passages and eyes for signs of larvae (maggot) infestation. Seek veterinary advice for immediate treatment of open wounds, including dehorning and castration sites and preventive use of topical and systemic insecticides. Review biosecurity plans with the farm or ranch veterinarian. Original article by the LSU AgCenter here.
Breaking: Justin Timberlake Reveals He Has Lyme Disease
When a major celebrity opens up about a personal health struggle, public attention often follows. That’s certainly the case after Justin Timberlake recently revealed that he is battling Lyme disease—a condition that affects nearly half a million Americans each year but remains widely misunderstood. Timberlake’s announcement is bringing renewed focus to the causes, risks, and complexities of Lyme disease, including how it spreads, where it’s most prevalent, and what individuals can do to protect themselves. With tick season still active in many regions, this moment offers an opportunity to better inform the public—and we’ve identified a group of leading experts who can help do just that. From microbiologists and epidemiologists to entomologists and disease ecologists, the following researchers bring a wide range of expertise on Lyme disease, tick biology, and environmental risk factors. Whether you're a journalist looking for credible sources, a public health communicator, or simply someone trying to make sense of this rising threat, these experts are available to provide clarity and context in the wake of this headline-making health disclosure. Featured Experts A highly media‑quoted microbiologist specializing in Lyme and other tick‑borne diseases. He runs TickReport, a service that tests ticks and interprets exposure risks. Insights on... How celebrities like Timberlake amplifying Lyme awareness may shift public perception and testing demand. The relevance of tick season timing and geographic risk zones. How tick testing works and what patients should know post‑exposure. Over two decades studying Borrelia burgdorferi and blacklegged ticks, with strong expertise in disease ecology and conservation medicine. Insights on... The biology of transmission and the tick’s life cycle—what leads to infection risk. How habitat and ecological shifts may affect Lyme exposure risks. Wildlife‑human disease interface in increasingly peri‑urban settings. Focuses on landscape ecology and patterns of vector‑borne disease emergence including Lyme disease. Insights on... How environmental changes (e.g. urban sprawl, climate trends) are altering Lyme disease risk maps. Predictive models: where Lyme is emerging next. Implications for public health messaging given high-profile cases like Timberlake’s. Specializes in tick taxonomy and vector species genetics—ideal for deeper background on tick diversity and distribution. Insights on... Which tick species carry Lyme and how misidentification can confuse diagnosis. Emerging tick species or genetic strains and what they mean for prevention. Geographic spread and species shift over time. His research examines geographic patterns of Lyme disease, including why incidence varies regionally in the U.S. Insights on... Why Lyme is more prevalent in certain states—even those outside Timberlake’s or his fans’ travel zones. Human behavioral and habitat factors (e.g. suburban greenspace vs. deep woods). What seasonal changes in tick behavior tell us about infection risk. Story Angles to Explore Celebrity spotlight on Lyme disease: How high‑profile cases can impact media attention, funding, public awareness, and testing demand. Diagnosis and prevention: From exposure to testing (e.g., TickReport), early symptoms, treatment windows, and what experts recommend post‑bite. Ecology and environment: Why Lyme is expanding geographically, and how climate and land‑use change influence risk. Tick evolution and identification: Educating the public on which ticks transmit Lyme, emerging strains, and challenges in correct tick identification. Regional variation in risk: Breakdowns of why some states or regions are Lyme hotspots and how that aligns with the celebrity’s likely exposure zones or fan geography. Looking for more Experts? Visit www.expertfile.com or download ExpertFile for your phone.
LSU Lab Helps Louisiana Prepare for Hurricanes, Drought, even Saharan Dust
Any hurricane that forms in the Gulf of America is a direct threat to Louisiana and its neighboring states. But most seasonal forecasts focus on the entire North Atlantic Basin, including areas where storms may never come close to any land, much less the U.S. Gulf Coast. A Gulf-specific forecast developed at LSU’s Coastal Meteorology (COMET) Lab addresses that issue by providing storm information specifically geared toward the Gulf region. The lab is run by Paul Miller, an associate professor at LSU who founded it in 2019. “We decided that a Gulf-specific forecast could help state officials and Gulf-area residents better understand how active the upcoming season might be in their part of the Atlantic,” said Miller, who teaches in the Department of Oceanography & Coastal Sciences in the College of the Coast & Environment. Miller said the LSU-Velocity Risk Gulf Hurricane Outlook is one example of how the COMET Lab delivers real benefits to Louisiana. “A lot of forecasts tend to align with each other each year. But ours works a lot differently than some of the other forecasts that are geared towards larger areas of the ocean,” he said. “We’re not the world’s leading hurricane research lab—and we don’t try to be. Instead, we prioritize meeting the largest research gaps relevant to Louisiana residents, spanning a wide variety of weather hazards. “We want to make sure Louisianans experience a clear return-on-investment from our lab’s activities.” Ways the lab supports the state also include: Helping forecast storm surge in real time and informing the decision on when to close flood barriers before a tropical system hits land. Developing rainfall models to support flood prevention efforts. Studying weather patterns that cause drought and low coastal water levels that can lead to marsh loss during dry spells on the Gulf Coast. Saharan Dust Research One area of study that incorporates both air quality and tropical weather is the lab’s research on Saharan dust clouds, which are blown across the Atlantic in an air mass called the Saharan Air Layer, or SAL. “So, this sort of far-off distant concept of Saharan dust is actually something that is kind of important to folks here in Louisiana,” Miller said. This dust can shut down thunderstorm activity in the U.S. Caribbean territories, a key area of research in the COMET Lab, and cause respiratory problems when it reaches the Southeast U.S. The SAL can also suppress hurricane activity in the Atlantic. “Our lab just launched a new project with the Office of Naval Research to determine how dust-dimmed sunlight can affect ocean temperatures in the Atlantic’s most active hurricane breeding grounds,” Miller said. Read the full story here.
AU research team awarded $4.4 million American Heart Association grant
A research team at Augusta University, led by Jennifer C. Sullivan, PhD, has secured a $4.4 million grant from the American Heart Association to study the risk factors for cardiovascular and kidney diseases and how they impact women. Sullivan’s research center, “Disruptions in cardiorenal free fatty acid metabolism in Cardiovascular Kidney Metabolic Syndrome,” is part of a larger $15 million project titled “Strategically Focused Research Network on Cardiovascular Kidney Metabolic Syndrome: Heterogeneity in Women.” The overarching AHA project is aimed at learning why women may be more likely to develop cardiovascular and kidney diseases due to certain unique risk factors and life stages. Research teams from Massachusetts General Hospital and The Ohio State University were also chosen. “I think this is a huge step for Augusta University as we continue to distinguish ourselves and the research that we have here focused on the health of women,” said Sullivan, dean of The Graduate School. “This grant is particularly impactful as we look to advance and improve the health of women, not just in Georgia, but for the entire country.” According to the Healthy Georgia Report, produced by AU’s School of Public Health, Georgia has the 23rd highest rate of obesity in the United States. Among the women living in the state, 38.3% of them, as well as 37.5% of people living in rural areas, suffer from obesity. “It’s great that we are able to represent the state of Georgia because our state has such a high prevalence for obesity rates,” said Sullivan, who is the director of AU’s SCORE project “Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk).” “It’s important for us to understand that different populations have distinct needs. You can’t talk about a one-size-fits-all approach to health. This is really about trying to understand how different groups are impacted.” Each center is comprised of three teams, as well as a training component and an area partner. Together, they will explore obesity’s lifetime impact on CKM syndrome through three projects. CKM syndrome is a clinical term that describes the combined health effects of heart disease, kidney disease, diabetes and obesity, which puts people at high risk for heart attack, stroke and heart failure. According to the American Heart Association’s 2025 Heart Disease and Stroke Statistics, about 1 in 3 U.S. adults has at least three components of CKM syndrome, which include high blood pressure, abnormal cholesterol, high blood glucose (sugar), impaired kidney function and excess body weight. The first project is led by Daria Ilatovskaya, PhD, and Justine Abais-Battad, PhD, and will look at aging and Western diet-induced CKMS mechanisms in obesity. Ilatovskaya is an associate professor and the graduate program director for the Doctor of Philosophy in Physiology program, and Abais-Battad is an assistant professor in the Department of Physiology with the Medical College of Georgia at Augusta University. The second component, led by Jessica Faulkner, PhD, an assistant professor in MCG’s Physiology department, will study obesity-associated mechanisms of CKMS in pregnancy. The third project, led by Stephen Coughlin, PhD, with Marlo Vernon, PhD, is looking at CKMS epidemiology, associations with obesity, CVD/CKD. Coughlin is the program director for the Master of Science in Epidemiology and professor of epidemiology in the School of Public Health’s Department of Biostatistics, Data Science, and Epidemiology, while Vernon is an associate professor with MCG’s Georgia Prevention Institute and SPH’s Department of Community and Behavioral Health Sciences. Additionally, the team will talk to women and health care providers from a variety of backgrounds and experiences to assess current knowledge and interest levels in heart health and use that information to develop programs that may help treat and prevent disease. There is also a training director, Alison Kriegel, PhD, a professor in the Department of Physiology, and a core director, Guido Verbeck, PhD, chair and professor of the Department of Chemistry and Biochemistry in the College of Science and Mathematics. “We have a strong blend of clinical epidemiology and basic science, as well as a training component, which we will fill with post-doctoral fellows,” Sullivan said. “Dr. Ilatovskaya, Dr. Faulkner, Dr. Abais-Battad and Dr. Vernon are all a part of our ROAR grant, and, while this isn’t directly related to that program, it allowed us to demonstrate how we are already well positioned to work together to amplify our ability and increase awareness about the importance of the health of women.” The team has over 50 collaborative papers and has secured more than $13 million in collaborative funding to advance the health of women. They also all have experience training fellows and students to continue to expand their reach. “We already have a lot of the infrastructure in place for this kind of cross-disciplinary project, so we leaned very heavily into our connections and the expertise we have here at Augusta University. It’s set up very similar to our ROAR program, so this is something that was really organic in nature,” Sullivan said. The American Heart Association has invested almost $300 million to establish 18 Strategically Focused Research Networks, each aimed at addressing a key strategic issue identified by the association’s volunteer Board of Directors. Prior networks have been studying a wide variety of important topics including, but not limited to, prevention, hypertension, the health of women, heart failure, obesity, vascular disease, atrial fibrillation, arrhythmias/sudden cardiac death, cardiometabolic health/type 2 diabetes, health technology, cardio-oncology, the biological impact of chronic psychosocial stress and the role of inflammation in cardiovascular health. Each network centers around scientific knowledge and knowledge gaps, prevention, diagnosis and treatment of the key research topic. Three to six research centers make up each network, bringing together investigators with expertise in basic, clinical and population/behavioral health science to find new ways to diagnose, treat and prevent heart disease and stroke. Funding scientific research and discovery through initiatives like these awards is a cornerstone of the century-old American Heart Association’s lifesaving mission. The association has now funded more than $5.9 billion in cardiovascular, cerebrovascular and brain health research since 1949, making it the single largest non-government supporter of heart and brain health research in the United States. New knowledge resulting from this funding continues to save lives and directly impact millions of people in every corner of the U.S. and around the world. Looking to know more about the amazing research happening at Augusta? To connect with Dr. Sullivan, simply click on her icon to arrange an interview today.
FAST nanotechnology unveiled at Rome Global Congress by AU scientist
Stephen Hsu, PhD, a professor at the Dental College of Georgia at Augusta University, unveiled his groundbreaking nanotechnology, known as FAST, during a keynote address at the 8th World Congress on Infectious Diseases in Rome, Italy. FAST, or Facilitated Self-Assembling Technology, offers a revolutionary way to convert compounds that are difficult to dissolve in water into stable nanoparticles. This innovation could transform drug development, viral infection prevention, hospital hygiene and more. “FAST takes a completely different approach from traditional nanotechnology,” Hsu explained. “Unlike methods that rely on polymers, metals, surfactants, fat-based carriers or complex engineering processes, FAST allows compounds to self-assemble into nanoparticles with minimal effort. This makes drugs that were once nearly impossible to formulate in water stable, effective and practical for medical and consumer use.” At the heart of this innovation is EC16, or EGCG-palmitate, a lipid-soluble compound derived from green tea. Known for its antioxidant, anticancer, anti-inflammatory and antimicrobial properties, green tea has long been studied but is challenging to use in clinical settings due to stability issues. FAST overcomes these limitations, transforming EC16 and other hydrophobic compounds into water-friendly nanoparticles. “You can’t even tell the particles are there,” said Hsu. “They look just like water. I made several different formulations in one afternoon in my lab. It’s that fast and simple.” A natural solution to global challenges Hsu’s work is the culmination of decades of research and a deeply personal journey. He credits green tea with helping him survive illness during his youth in a labor camp in China. Now, he’s turning its natural properties into cutting-edge therapies with the hope of helping more people. “I’ve been drinking green tea my entire life,” Hsu said. “Now, we’re turning its benefits into medical-grade treatments.” Supported by over $600,000 in NIH grants, Hsu’s team is developing applications like alcohol-free disinfectants and nasal sprays to prevent respiratory virus infections. One promising product is an EC16-based disinfectant that is natural, non-toxic and highly effective against tough pathogens, like norovirus and C. difficile, a bacterium that can cause severe diarrhea. “That’s a big deal for schools, hospitals and places like cruise ships, where these infections spread easily,” he said. Tackling long COVID and beyond Among FAST’s most promising applications is a nasal spray developed to prevent or treat long COVID and other respiratory illnesses. The spray, currently undergoing preclinical testing, targets viral entry points in the nasal mucosa, where infections often begin. “Our goal is to help immunocompromised patients and those with lingering symptoms like brain fog and loss of smell,” Hsu said. “We’ve already seen strong in vitro results against human coronavirus and norovirus.” In addition to nasal and topical treatments, Hsu’s team has developed oral formulations of EC16 that remain stable through the stomach’s acidic environment, critical for treating gastrointestinal viruses and potentially inflammatory bowel diseases like Crohn’s. “We found that even without direct contact with the virus, the EC16 nanoparticles taken by mouth can reduce infection,” Hsu explained. “That’s a major step forward in treatment of digestive tract viral infections.” A platform for the future of medicine FAST isn’t limited to green tea compounds. Hsu’s method can transform a wide range of hydrophobic compounds like cannabidiol, ivermectin, quercetin, procyanidin and retinoic acid, as well as hundreds of existing drugs, into nanoparticle suspensions that are stable and water-friendly. This has huge implications,” said Hsu. “Up to 90% of new drug candidates have poor water solubility and low bioavailability, which limits their effectiveness. With FAST, we can change that.” His lab is already exploring applications in Alzheimer’s research, cancer therapy, oral health and even anti-biofilm coatings to prevent hospital infections. These products, along with the nasal spray, are expected to hit the market this fall. Hsu is currently finalizing publications and preparing patent filings to protect and expand the reach of FAST. While optimistic, he remains cautious. “The results so far are phenomenal. FAST could be a new chapter in how we fight disease and deliver medicine,” Hsu said. Looking to know more about FAST nanotechnology and the research happening at Augusta University? To connect with Dr. Stephen Hsu - simply contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.
The Impact of Counterfeit Goods in Global Commerce
Introduction Counterfeiting has been described as “the world’s second oldest profession.” In 2018, worldwide counterfeiting was estimated to cost the global economy between USD 1.7 trillion and USD 4.5 trillion annually, as well as resulting in more than 70 deaths and 350,000 serious injuries annually. It is estimated that more than a quarter of US consumers have purchased a counterfeit product. The counterfeiting problem is expected to be exacerbated by the unprecedented shift in tariff policy. Tariffs, designed as an import tax or duty on an imported product, are often a percentage of the price and can have different values for different products. Tariffs drive up the cost of imported brand name products but may not, or only to a lesser extent, impact the cost of counterfeit goods. In this article, we examine the extent of the global counterfeit dilemma, the role experts play in tracking and mitigating the problem, the use of anti-counterfeiting measures, and the potential impact that tariffs may have on the flow of counterfeit goods. Brand goods have always been a target of counterfeits due to their high price and associated prestige. These are often luxury goods and clothing, but can also be pharmaceuticals, cosmetics, and electronics. The brand name is an indication of quality materials, workmanship, and technology. People will pay more for the “real thing,” or decide to buy something cheaper that looks “just as good.” In many cases, “just as good” is a counterfeit of the brand name product. A tariff is an import tax or duty that is typically paid by the importer and can drive up the cost of imported brand name products. For example, a Yale study has shown that shoe prices may increase by 87% and apparel prices by 65%, due to tariffs. On the other hand, counterfeit products don’t play by the rules and can often avoid paying tariffs, such as the case of many smaller, online transactions, shipped individually. Therefore, we expect to see an increase in counterfeit products as well as a need to increase efforts to reduce the economic losses of counterfeiting. The Scale of the Counterfeit Problem In their 2025 report, the Organisation for Economic Co-operation and Development (OECD) and the European Union Intellectual Property Office (EUIPO), estimated that in 2021, “global trade in counterfeit goods was valued at approximately USD 467 billion, or 2.3% of total global imports. This absolute value represents an increase from 2019, when counterfeit trade was estimated at USD 464 billion, although its relative share decreased compared to 2019 when it accounted for 2.5% of world trade. For imports into the European Union, the value of counterfeit goods was estimated at USD 117 billion, or 4.7% of total EU imports.” In a 2020 report, the US Patent and Trademark Office (USPTO) estimated the size of the international counterfeit market as having a “range from a low of USD 200 billion in 2008 to a high of USD 509 billion in 2019.” According to the OEDC / EUIPO General Trade-Related Index of Counterfeiting for economies (GTRIC-e), China continues to be the primary source of counterfeit goods, as well as Bangladesh, Lebanon, Syrian Arab Republic, and Türkiye. Based on customs seizures in 2020-21, the most common items are clothing (21.6%), footwear (21.4%), and handbags, followed by electronics and watches. Based on the value of goods seized, watches (23%) and footwear (15%) had the highest value. However, it should be noted that items that are easier to detect and seize are likely to be overrepresented in the data. Although the share of watches declined, and electronics, toys, and games increased, it remains unclear whether this represents a long term trend or just a short term fluctuation. In general, high value products in high demand continue to be counterfeited. Data from the US Library of Congress indicates that 60% – 80% of counterfeit products are purchased by Americans. The US accounts for approximately 5% of the world’s consumers; however, it represents greater than 20% of the world’s purchasing power. Though it is still possible to find counterfeit products at local markets, a large number of counterfeit goods are obtained through online retailers and shipped directly to consumers as small parcels classified as de minimis trade. This allows for the duty-free import of products up to USD 800 in value. Counterfeit items may be knowingly or unknowingly purchased from online retailers and shipped directly to consumers, duty-free. Purchased products can be shipped via postal services, classified as de minimis trade. Approximately 79% of packages seized contained less than 10 items. Given the size and volume of the packages arriving daily, many or most will evade scrutiny by customs officials. This means of import is increasing over time. In 2017-19 it was 61% of seizures. By 2020-21, it was 79%. Economic Impact of Counterfeiting The scale of the counterfeiting problem has significant impacts on the US economy, US business interests, and US innovations in lost sales and lost jobs. Moreover, counterfeit products are often made quickly and cheaply, using materials that may be toxic. The companies producing these goods may not dispose of waste properly and may dump it into waterways, causing significant environmental consequences. Counterfeit products from electrical equipment and life jackets to batteries and smoke alarms may be made without adhering to safety standards or be properly tested. These products may fail to function when you need it and may lead to fire, electric shock, poisoning, and other accidents that can seriously injure and even kill consumers. Counterfeit cosmetics and pharmaceuticals can also lead to injuries by either including unsafe ingredients or by failing to provide the benefits of the real product. The Tariff Counterfeit Connection Tariffs may be seen as a tax on consumers and raise the price of imported products that are already the target of counterfeiters such as luxury leather products and apparel. It’s commonly understood that raising prices on genuine products can only drive up the demand for counterfeit goods. In general, consumers will have less disposable income and the brand goods they desire will cost more which is bound to increase the demand for counterfeit goods. Although recent changes removing the USD 800 tax exemption on de minimis shipments from China and Hong Kong will make it more expensive for counterfeiters to ship their goods internationally, tariffs are typically applied as a percentage of the cost of an object. This will cause the price of more expensive legitimate goods to increase even more than the cheaper counterfeit goods and likely make the counterfeit products even more attractive economically. Therefore, we expect to see an increase in counterfeit products as well as an increase in efforts to reduce the economic losses of counterfeiting. The Role of Technical Experts in Counterfeit Detection Technical experts play an important role in both the prevention and detection of counterfeits and helping to identify counterfeiting entities. Whether counterfeit money, clothing, shoes, electronics, cosmetics or pharmaceuticals, the first step in fighting counterfeits is detecting them. In some cases, the counterfeit product is obvious. A leather product may not be leather, a logo may be wrong, packaging may have a spelling mistake, or a holographic label may be missing. These products may be seized by customs. However, some counterfeit products are very difficult to detect. In the case of a counterfeit memory card with less than the stated capacity or a pharmaceutical that contains the wrong active ingredient, technical analysis may be needed to identify the parts. Technical analysis may also be used to try and identify the source of the counterfeit goods. For prevention measures, manufacturers may use radio frequency identification (RFID) or Near Field Communication (NFC) tags within their products. RFID tags are microscopic semiconductor chips attached to a metallic printed antenna. The tag itself may be flexible and easy to incorporate into packaging or into the product itself. A passive RFID requires no power and has sufficient storage to store information such as product name, stock keeping unit (SKU), place of manufacture, date of manufacture, as well as some sort of cryptographic information to attest to the authenticity of the tag. A simple scanner powers the tag using an electromagnetic field and reads the tag. If manufacturers include RFID tags in products, an X-ray to identify a product in a de minimis shipment (perhaps using artificial intelligence technology) and an RFID scanner to verify the authenticity of the product can be used to efficiently screen a large number of packages. Many products also may be marked with photo-luminescent dyes with unique properties that may be read by special scanners and allow authorities to detect legitimate products. Similarly, doped hybrid oxide particles with distinctive photo-responsive features may be printed on products. These particles, when exposed to laser light, experience a fast increase in temperature which may be quickly detected. For either of these examples, the ability to identify legitimate products, or – due to the absence of marking – track counterfeit products, allows authorities to map the flow of the counterfeit goods through the supply chain as they are manufactured, shipped, and are exported and imported to countries. For many years, electronic memory cards such as SD cards and USB sticks have been counterfeited. In many cases, the fake card will have a capacity much smaller than listed. For example, a 32GB memory card for a camera may only hold 1GB. Sometimes, these products may be identified by analyzing the packaging for discrepancies from the brand name products. In other cases, software must be used to verify the capacity and performance of each one, which is time-consuming when analyzing a large number of products. Forensic investigators, comprised of forensic accountants and forensic technologists, are heavily involved in efforts to combat this illicit trade. By analyzing financial records, supply-chain data, and transaction histories, they trace the origins and pathways of counterfeit products. Their work often involves identifying suspicious procurement patterns, shell companies, and irregular inventory flows that signal counterfeit activity. Forensic investigators often begin by mapping the counterfeit supply chain, an intricate web that often spans continents. Using data analytics, transaction tracing, and inventory audits, they identify anomalies in procurement, distribution, and sales records. These methodologies help pinpoint the origin of counterfeit goods, the intermediaries involved, and the final points of sale. By reconstructing the flow of goods and money, forensic investigators can begin to unmask activities. Cross-border partnerships are essential for tracking assets, sharing insights, and coordinating with financial regulators. Public-private partnerships further enhance the effectiveness of anti-counterfeiting efforts. Forensic investigators often serve as bridges between government agencies, brand owners, and financial institutions, facilitating the exchange of key information. These partnerships increase information-sharing, streamline investigations, and amplify the impact of enforcement actions. A promising development in this space is the World Customs Organization’s Smart Customs Project, which integrates artificial intelligence to detect and intercept counterfeit goods. Forensic investigators can leverage this initiative by analyzing AI-generated alerts and incorporating them into broader financial investigations, which allows for faster and more accurate identification of illicit networks. Jurisdictional complexity is a major hurdle in anti-counterfeiting efforts. Forensic investigators work closely with legal teams to navigate these challenges to ensure that investigations comply with local laws, and evidence is admissible and can withstand scrutiny in court, especially when dealing with offshore accounts and international money laundering schemes. Forensic investigators follow the money, tracing illicit profits through bank accounts, shell companies, and cryptocurrency transactions. Their findings not only help recover stolen assets but also support disputes by providing expert testimony that quantifies financial losses and identifies the bad actors. Conclusion Imitations of brand name products have become more convincing, harder to detect, and the sources of the counterfeit goods more difficult to identify. While counterfeiting clearly has evolved because of technological advancements, e-commerce, and the growing sophistication of bad actors, the process has now been complicated even further by the unpredictable tariff and trade policies that are affecting businesses worldwide. Consequently, companies need to take a multi-faceted approach to these new challenges introduced into the counterfeiting of products by tariffs. By engaging high-tech product authentication measures, utilizing technology-based alerts about counterfeits, and retaining the specialized skills of forensic investigators and other experts, companies will be able to navigate the risks posed by the complex and changing relationship between tariffs and counterfeit goods. To learn more about this topic and how it can impact your business or connect with James E. Malackowski simply click on his icon now to arrange an interview today. To connect with David Fraser or Matthew Brown - contact : Kristi L. Stathis, J.S. Held +1 786 833 4864 Kristi.Stathis@JSHeld.com
How ChristianaCare Built a Blueprint for Better Caregiver Health and Lower Costs
By Donna Antenucci, MHA, BSN, RN, and Emily Sahm, EA We know rising health care costs can feel overwhelming for both employers and employees. As Delaware’s largest private employer — with nearly 23,000 employees, spouses and dependents enrolled in our self-funded health plan — ChristianaCare faces these challenges every day. That’s why we’re committed to finding smart, innovative solutions that improve employee health while keeping costs in check. We don’t stop there — ChristianaCare partners with businesses that have an interest in providing high-quality health care for their employees while keeping costs manageable. Prioritizing preventive care The key to a healthier, more resilient workforce is tackling health issues early in order to prevent the need for costly emergency or “rescue” care. By prioritizing prevention and early intervention, we’ve made progress in improving employee health while controlling costs. In 2023, inpatient facility costs for our employees — which include hospital admissions for surgeries, medical treatments and other care requiring overnight stays — dropped by 9%. Wellness incentives and chronic disease management that shifted care to more cost-effective outpatient settings are driving these results. One of ChristianaCare’s differentiators is CareVio®, our care coordination and chronic disease management platform. CareVio provides personalized support to help employees and their families manage conditions and stay on track with preventive care. CareVio’s diabetes program, for example, has delivered remarkable results. Nearly all participants improved their blood sugar levels in 2023, with average A1c reductions of 1.7 points. Enhancing primary care and wellness programs We’ve also focused on encouraging primary care visits through collaboration between our Population Health and Total Rewards teams. Together, we designed a voluntary wellness incentive program that rewards employees and their families for healthy choices, including support for tobacco-cessation programs to help employees quit smoking and lead healthier lives. In 2023, we expanded our wellness incentive program to include primary care visits for employees and their spouses. Over the next eighteen months, primary care utilization increased over 10%, rising from 66% to 77% as of January 2025. Employees who stay connected to primary care catch health problems early and build stronger relationships with their doctors. We’ve launched programs targeting specific health needs. Our breast cancer screening initiative, focused on women ages 52 to 74, increased participation rates from 63% to 72% in 2023, exceeding our target. Additionally, the CareVio metabolic health program is helping a growing number of participants manage complex conditions with tailored support. Flexibility is essential. That’s why we created the Center for Virtual Health, which provides virtual-first primary care to more than 1,200 employees. This program makes high-quality, preventive care more accessible. Employees can fit care into their schedules while maintaining consistent support for their health. We encourage employees to stay up to date on immunizations by offering frequent vaccination events and tying participation to eligibility for the Caregiver Rewards Program payout. By making it easy and rewarding to stay protected, we’re fostering a safer, healthier workplace for everyone. Collaborative networks and cost management In January 2023, we announced the ChristianaCare Clinical Alliance, a new clinically integrated network in partnership with Highmark. Implemented in our employee health plan in July 2024, the network connects ChristianaCare-employed and community clinicians to provide evidence-based, coordinated care. Focused on improving wellness and managing chronic conditions, the Clinical Alliance is helping caregivers and their families stay healthier while reducing costly emergency visits and hospital stays. Employees who choose Clinical Alliance providers also enjoy lower deductibles for their care. Through all these initiatives, we are making a meaningful difference for our caregivers and our costs. In 2023, thanks to our focus on prevention and smarter care delivery, we kept our overall health care cost growth below the national average. Healthier employees lead to lower expenses and a more engaged, productive workforce. By showing that we value employee health, we’re creating a stronger, more resilient workplace. To learn how ChristianaCare can help you provide better care and control costs for your workforce, contact Donna Antenucci at donna.antenucci@christianacare.org. Donna Antenucci is vice president of population health operations for ChristianaCare. Emily Sahm is vice president of Total Rewards for ChristianaCare.
Georgia Southern University’s Office of Student Wellness and Health Promotion, Jiann-Ping Hsu College of Public Health (JPHCOPH) Center for Addiction Recovery and Health Services have partnered to provide overdose prevention education to the campus community. The University will distribute naloxone, which is used to rapidly and temporarily reverse the effects of an opioid overdose, allowing time for first responders to arrive and initiate further intervention, to the campus community at no cost. Savannah nonprofit No More O.D.s donated a large quantity of naloxone to Georgia Southern for this purpose. “The health and safety of our campus and the many visitors it welcomes are of high priority,” said Shay Little, Ph.D., vice president for Student Affairs. “By increasing access to naloxone we are equipping our community with another life-saving tool.” Georgia Southern Public Health Administrator Sean Bear, DPH, agrees. “Naloxone is a life-saving medication,” he noted. “It is safe, fast-acting and easy to use.” Although many in the Georgia Southern community do not consume alcohol or other recreational substances, opioid overdoses can occur under a number of circumstances. Misuse of prescription opioids provided by a health care provider or the use of illegal opioids can result in negative health consequences, including overdoses. Some common prescription opioids include codeine, morphine, hydrocodone and oxycodone, among others. Counterfeit pills designed to look like prescription opioids often contain a synthetic opioid known as fentanyl, with many of these pills containing enough fentanyl in just one dose to cause an opioid overdose. “The primary aim of distributing naloxone and providing education on overdose prevention, recognition and response is to save lives,” said Robert Bohler, Ph.D., JPHCOPH assistant professor. Just as AED/CPR first aid boxes are placed strategically across campus, naloxone kits and utilization instructions will be placed in high-traffic, high-risk areas. Distribution locations include the Campus Food Pantries (all campuses), Center for Addiction and Recovery (Statesboro Campus), Health Centers (Statesboro and Armstrong campuses), Counseling Centers (Statesboro and Armstrong campuses), and Student Wellness and Health Promotion (Statesboro and Armstrong campuses). “All naloxone packages come with instructions, however, additional educational information, such as a video link on how to administer naloxone, where to find additional information and more will be available at each of these distribution locations,” said Gemma Skuraton, DPH, director of Student Wellness and Health Promotion. Universities play a vital role in promoting harm-reduction strategies. As such, Georgia Southern is committed to ensuring the availability, accessibility and education surrounding naloxone on each of its campuses. Educational initiatives will focus on overdose prevention, recognizing signs and symptoms of overdose, overdose response planning, naloxone administration, legal protections (Georgia’s 911 Medical Amnesty Law and Georgia Southern’s Amnesty Protocol), bystander intervention, and treatment and recovery service availability on campus and in the community. You can sign-up for an open workshop to learn more on the Student Wellness and Health Promotion webpage: Interested in learning more? If you want to connect with any of the experts from this story and want to book time to talk or interview, then let us help - simply contact Georgia Southern's Director of Communications Jennifer Wise at jwise@georgiasouthern.edu to arrange an interview today.
University-wide mental health services strengthened by Georgia Southern’s JED Campus initiative
As a result of Georgia Southern’s commitment to increasing student awareness and access to mental health resources, the University has recently been named a full JED Campus (JED) Member university. Georgia Southern recently completed a four-year partnership with JED, a national collegiate mental health program that guides colleges through a collaborative process of building comprehensive systems, programs and policy development with customized support to build upon existing student mental health, substance use and suicide prevention efforts. Along with the JED efforts, Georgia Southern has significantly increased student awareness and access to mental health resources. A recent report shows that 83% of Georgia Southern University students agree that the administration is listening to the concerns of students around health and wellness. This is a 15% increase since 2020. In 2020, the University System of Georgia launched several system-wide initiatives and resources to increase the mental health awareness and resources for all of its institutions. One of these initiatives was to fund the enrollment of all institutions in the JED Campus program. This included the creation of a JED campus team, an initial campus mental health climate study conducted by the Healthy Minds Institute on behalf of JED, the completion of a Georgia Southern self-study, a campus site visit by JED and the development and completion of a four-year strategic plan. “Engaging in the four-year JED Campus process has enabled Georgia Southern to strengthen and expand its university-wide commitment to the mental health of our students, faculty and staff,” said Jodi K. Caldwell, Ph.D., Counseling Center executive director & JED Campus team lead. “The JED team remains committed to growing Georgia Southern’s efforts in providing awareness, education, resources and support for the well-being of our community. We are grateful to the University System of Georgia, whose support funded this opportunity for all USG institutions and to the support of our Georgia Southern administration.” Recently, the University has increased awareness and resources through programs like the H.E.R.O. Folder. Students aware of mental health outreach efforts grew from 40% to 60%, and those knowing where to seek professional help increased from 78% to 84%, according to the JED feedback report. Additional findings can be found in the full report at the bottom of this article. Georgia Southern will now be considered an alumni of the program, and will continue several of the programs and initiatives launched with JED. If you're interested in learning more about Georgia Southern's partnership with JED and want to book time to talk or interview with Jodi Caldwell then let us help - simply click on her icon now contact Georgia Southern's Director of Communications Jennifer Wise at jwise@georgiasouthern.edu to arrange an interview today.
